The FDA issued a new warning about some of the popular diabetes drugs being used for weight loss after the agency "received adverse event reports after patients used compounded semaglutide." That's the generic name for medications like Ozempic and Wegovy. New York endocrinologist Dr. Florence Comite joins CBS News to discuss the risks of taking off-brand versions.
